IP Library Granted Patent US 6,960,351
Granted Patent B2
US 6,960,351 · App. 10/624,081 · Granted Nov 1, 2005

Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,960,351
App. No.
10/624,081
Granted
Nov 1, 2005
Kind
B2
Abstract

An immunoisolatory vehicle for the implantation into an individual of cells which produce a needed product or provide a needed metabolic function. The vehicle is comprised of a core region containing isolated cells and materials sufficient to maintain the cells, and a permselective, biocompatible, peripheral region free of the isolated cells, which immunoisolates the core yet provides for the delivery of the secreted product or metabolic function to the individual. The vehicle is particularly well-suited to delivery of insulin from immunoisolated islets of Langerhans, and can also be used advantageously for delivery of high molecular weight products, such as products larger than IgG. A method of making a biocompatible, immunoisolatory implantable vehicle, consisting in a first embodiment of a coextrusion process, and in a second embodiment of a stepwise process. A method for isolating cells within a biocompatible, immunoisolatory implantable vehicle, which protects the isolated cells from attack by the immune system of an individual in whom the vehicle is implanted. A method of providing a needed biological product or metabolic function to an individual, comprising implanting into the individual an immunoisolatory vehicle containing isolated cells which produce the product or provide the metabolic function.

Claims (3)

1. An implantable immunoisolatory vehicle for providing a biologically active product or function to an individual, the immunoisolatory vehicle comprising:

(a) a core comprising a volume in excess of 1 μl and at least about 10 4 living cells dispersed in a biocompatible matrix formed of a hydrogel, said cells being capable of secreting a selected biologically active product or of providing a selected biological function to an individual; and

(b) an external diffusional surface jacket surrounding said core formed of a biocompatible hydrogel material free of said cells projecting externally thereof, wherein the hydrogel material does not ionically bond to a polymer of opposite charge on the core during formation of the jacket and wherein the jacket and the core form an interface free of an intermediate linking layer said jacket having a molecular weight cutoff below the molecular weight of substances essential for immunological rejection of the cells but permitting passage of substances between the individual and core through said jacket required to provide said biological product or function.

Assignments (1)
SECURITY AGREEMENT Recorded Dec 23, 2010
From: NEUROTECH USA, INC.
To: LFG AMERICA PTY LIMITED
Reel/Frame 025562/0340 →